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Abstract
Background: Advanced genomic techniques such as Next-Generation-Sequencing (NGS) and gene expression
profiling, including NanoString, are vital for the development of personalised medicines, as they enable molecular
disease classification. This has become increasingly important in the treatment of cancer, aiding patient selection.
However, it requires efficient nucleic acid extraction often from formalin-fixed paraffin-embedded tissue (FFPE).
Methods: Here we provide a comparison of several commercially available manual and automated methods for
DNA and/or RNA extraction from FFPE cancer cell line samples from Qiagen, life Technologies and Promega.
Differing extraction geometric mean yields were evaluated across each of the kits tested, assessing dual DNA/RNA
extraction vs. specialised single extraction, manual silica column based extraction techniques vs. automated
magnetic bead based methods along with a comparison of subsequent nucleic acid purity methods, providing a
full evaluation of nucleic acids isolated.
Results: Out of the four RNA extraction kits evaluated the RNeasy FFPE kit, from Qiagen, gave superior geometric
mean yields, whilst the Maxwell 16 automated method, from Promega, yielded the highest quality RNA by
quantitative real time RT-PCR. Of the DNA extraction kits evaluated the PicoPure DNA kit, from Life Technologies,
isolated 2–14× more DNA. A miniaturised qPCR assay was developed for DNA quantification and quality
assessment.
Conclusions: Careful consideration of an extraction kit is necessary dependent on quality or quantity of material
required. Here we provide a flow diagram on the factors to consider when choosing an extraction kit as well as
how to accurately quantify and QC the extracted material.
Keywords: FFPE, DNA, RNA, Manual, Automated, Extraction
Background
Highly multiplexed assays, capable of profiling many gen-
etic biomarkers in a single experiment, are of rising im-
portance in the field of life sciences, enabling mapping of
entire biological pathways [1–5]. Our rapidly growing un-
derstanding of the molecular mechanisms driving disease
progression enables acceleration of personalised medicines
into the clinic, particularly in oncology [6–8]. Such assays
require sufficient quantities of high quality DNA and
RNA extracted from clinically relevant patient samples.
Formalin is the most widely used fixative, used for over
a century by hospitals to preserve clinical samples for long
term storage. Extensive collections of formalin fixed paraf-
fin embedded (FFPE) clinical samples exist worldwide,
representing an invaluable resource for prospective and
retrospective studies on archival tissue [9, 10]. However,
multiple factors influence the efficiency of formalin
fixation including tissue size, fixation temperature and
duration, and the amount of time that elapses before the
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sample is fixed [11]. The lack of standardised procedures
for collecting and processing tissue samples results in a
range of FFPE qualities across different sites which can be
further influenced by the age of the tissue block [10]. Sci-
entists are constantly faced with the challenge of obtaining
sufficient amounts of high quality nucleic acids from sub-
optimal FFPE samples containing minimal amounts of tis-
sue. Furthermore, the fixation process leads to the cross
linking of nucleic acids and proteins resulting in highly
fragmented nucleic acid species with amplimers around
100 bases. This can introduce sequence alterations and
mono methylol addition of nucleic acids which can impact
downstream PCR based assays [12–15]. A number of
companies supply off the shelf kits optimised for the ex-
traction of DNA and/or RNA from FFPE sections using
varying amounts of tissue. Therefore, we carefully selected
seven commercially available FFPE extraction kits with a
broad range of properties to assess nucleic acid yield and
the quality and purity of the extracted material.
Differing extraction methods were assessed: dual DNA/
RNA extraction vs. specialised single extraction, manual
silica column based extraction techniques vs. automated
magnetic bead based methods and finally a comparison
between extraction kits across a range of manufacturers.
A number of papers have been published previously com-
paring the performance of manual FFPE extractions kits
from different suppliers [16–18], with more recent studies
focusing on comparisons between automated extraction
methods and their manual counterpart in order to re-
duce the hands on time of laborious extraction pro-
cesses [19–22]. However, the studies use different
samples and methods for quantifying and assessing the
quality of the extracted material that are not always
comparable, making it challenging to cross compare
disparate data sets. It is for this reason that we present
a comprehensive analysis of seven selected kits using a
single sample set. In addition, we provide a head-to-
head comparison of commonly used platforms to aid
decisions around how to extract, quantify, and assess
the quality of nucleic acids.
Cell blocks were used to ensure sufficient sections could
be generated to enable robust analysis of each extraction
method; although tissue blocks were initially used, the ma-
terial was rapidly exhausted thereby preventing all extrac-
tion kits from being evaluated across all variables using
tissue from a single block. Cancer cell lines were cultured,
fixed in formalin and embedded in paraffin, to represent
the process of preserving clinical tissue whilst achieving a
homogenous cell population with known expression of
genes of interest for downstream evaluation. This ensured
that variability in this assessment is solely due to differ-
ences in the extraction kits and not by fixation methods,
times and heterogeneity of the tissue. An additional ad-
vantage of having a large quantity of cells embedded
within a block, is that it allows each kit to be tested using
optimal conditions, so significant differences between kits
can be identified.
Methods
Formalin fixed paraffin embedded cancer cell line blocks
Human chronic myeloid leukaemia and breast cancer cell
lines, used in this study, were obtained from the American
Type Culture Collection (ATCC) and the Deutsche
Sammlung von Mikroorganismen und Zellkulturen
(DSMZ). Cells were grown in T225 tissue culture
flasks in RPMI1640 media (phenol red free; Sigma)
supplemented with 10% foetal calf serum and 1% L-
Glutamine (Life Technologies Bethesda Research Labora-
tories Ltd) and maintained at 37 °C with 5% CO2. Each
cell line was passaged up to 3 times and at approximately
80% confluence, the cells were fixed in 10% neutral buff-
ered formalin for 24 h at room temperature before em-
bedding in paraffin wax. Consecutive 5 μm sections were
generated from each of the FFPE cell blocks using a stand-
ard microtome blade and fixed onto glass microscope
slides. All FFPE cell blocks and 5 μm sections were stored
at room temperature until nucleic acid extraction was
performed.
Nucleic acid extraction
Seven commercially available nucleic acid extraction kits
were used in this study (Table 1). Kits were selected
based on prior reviews of performance [21, 23] and their
extraction properties. Four of the kits tested, rely on the
selective binding of nucleic acids to silica columns, two
of the kits exploit binding to paramagnetic beads allow-
ing automation of the extraction and one kit tested did
not require nucleic acid binding to a solid interphase.
Another factor taken into account when selecting kits
was the suitability of the extracted material for use in
downstream applications including RT-qPCR, qPCR,
and gene expression analysis.
A total of 30 samples from 6 FFPE cell line blocks
were generated using each extraction method yielding a
total of 240 samples as one method extracted both
DNA and RNA. RNA extractions were performed on
the following cell line blocks: KCL22, MDA-MB-468,
MDA-MB-453 (fixed less than 6 months prior to this
work) and MDA-MB-231, MDA-MB-468 and MDA-
MB-453 (fixed 2–3 years prior to this work). DNA ex-
tractions were performed on the following cell line
blocks T47D, MDA-MB-468 and MDA-MB-453 from
each age group (Table 2). 15 consecutive 5 μm sections
were generated from each block and processed as 5 μm,
10 μm (2 combined sections), 15 μm (3 combined sec-
tions), 20 μm (4 combined sections) and 25 μm (5 com-
bined sections) in each extraction method. All FFPE
sections were deparaffinised using an automated protocol
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on the Leica autostainer XL, involving immersion into xy-
lene twice followed by immersion into 100% ethanol twice
then left to air dry for 15 min, with the exception of the
two Promega kits where no deparaffinisation was per-
formed. All extraction kits were used according to the
manufacturer’s instructions including elution volumes
quoted and all optional DNase 1 steps in RNA extractions.
Following deparaffinisation, the surface area of the cell
line pellet was checked by eye from consecutive sections
within a block to ensure they matched. All RNA samples
were stored at −80 °C and all DNA and cDNA samples
were stored at −20 °C throughout the study.
Quantitative and qualitative RNA assessment
Yield
RNA concentration was determined using the Qubit HS
RNA assay (Life Technologies, catalogue number Q32852)
on the Qubit 2.0 fluorometer. 1.0 μl of RNA in a total
200 μl volume of working solution was prepared. The
fluorescence of unknown RNA samples was measured
and converted to RNA concentration using a calibration
curve generated from newly prepared RNA standards at
0 ng/μl and 10 ng/μl.
Integrity
The extent of RNA fragmentation was assessed via capil-
lary chip electrophoresis. RNA samples at a concentration
≥5 ng/μl were tested using RNA 6000 nano LabChips.
The chips were run on the Agilent 2100 Bioanalyser
according to the manufacturer’s instructions.
Purity
RNA concentration and purity were measured on the
Nanodrop 2000 using 1 μl of RNA. The ratio between
the absorbance at 260 nm and 280 nm was used to
evaluate purity; we assumed ratios between 1.8 and 2.0
to be pure.
mRNA quality assessment
Multiplex quantitative 2-step reverse transcriptase PCR
was performed to assess mRNA quality for the same
sample set analysed on the Agilent. 7 μl of RNA at a
concentration of 5 ng/μl (quantified using the Qubit 2.0
fluorometer) was used to generate cDNA in a 10 μl total
extraction volume using the SuperScript VILO cDNA
synthesis kit (Life Technologies, Catalogue Number
11754-050) followed by incubation at 25 °C for 10 min,
42 °C for 60 min and 85 °C for 5 min.
The qPCR assay was prepared in Roche 384 well PCR
plates (product no. 04729749001) in a 10 μl reaction vol-
ume fired using an ECHO 525 non-contact micro dis-
penser (LabCyte). Three primer probe pairs were used
in each assay against the following housekeeping genes:
RPLP0 (CY5), RPL19 (FAM) and ACTB (CYAN500)
using three unique fluorophores compatible with the
Roche LightCycler480 PCR machine. 0.5 μl of cDNA at
3.5 ng/μl (within the linear range of the assay, Additional
file 1: Figure S1) was run in duplicate alongside negative
controls lacking the cDNA template on the Roche Light-
Cycler480 PCR machine with 1 pre incubation cycle at
95 °C for 10 min followed by 45 amplification cycles at
95 °C for 10 s, 60 °C for 30 s, 72 °C for 1 s before cooling
to 40 °C for 30 s. Data was analysed using the LightCycler
480 software (version 1.5.1.62) under the “Abs quant/ 2nd
Derivative Max analyses” programme. This software cal-
culated the average Cq per gene for sample duplicates; this
was then used to calculate the average across the 3 house
keeping genes and this value was used to compare mRNA
quality obtained using the different extraction kits, lower
Cq values indicated higher quality mRNA.
Quantitative and qualitative DNA assessment
For DNA to be used in downstream genomic tech-
niques, for example NGS, quality and quantity of ampli-
fiable DNA needs to be assessed. Qubit and Nanodrop
will not generate this information so Quantitative PCR
was performed for DNA quantification and quality as-
sessment, using the hgDNA Quantification and QC kit
from Kapa Biosystems (KK4960) as per the manufac-
turer’s instructions. Two amplicons from a conserved
single copy DNA locus were generated, one 41 bp in
length and one 129 bp in length. Amplification of the
41 bp target was used for quantitation of amplifiable
DNA. This was compared to data generated using the
129 bp assay, to ensure valid conclusion for the Qiagen
extraction kits that are less able to retain fragments
<100 bp. The 129 bp assay was used to assess DNA
quality, since poor DNA quality influences the ability to
amplify longer DNA fragments. The relative quality of
DNA samples was calculated by normalising the con-
centration obtained using the 129 bp assay against the
concentration obtained from the 41 bp assay, which
generates a Q-ratio value between 0 and 1 (0 represents
highly fragmented DNA whilst 1 represents high quality
DNA). Both assays were performed on the Roche Light-
Cycler480 PCR machine in a 3.0 μl reaction volume.
Data was analysed using the Roche LC480 software
using the “Abs quant/ 2nd Derivative Max analyses”
programme. This software calculated the average Cq
Table 2 Summary of the FFPE cell pellet blocks used in the study
<6 months of age >2 years of age
RNA extraction kits KCL22,
MDA-MB-468,
MDA-MB-453
MDA-MB-231,
MDA-MB-468,
MDA-MB-453
DNA extraction kits T47D,
MDA-MB-453,
MDA-MB-468
T47D,
MDA-MB-453,
MDA-MB-468
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value of duplicates, the standard deviation and DNA
concentrations were generated from a standard curve.
Statistical evaluation
Graphical representations were generated using TIBCO
Spotfire software version 5.0 and Microsoft Office Excel
2007. Data was represented as the geometric mean with
corresponding geometric standard error as the data was
found to have an asymmetrical distribution. The statis-
tical significance of the data was assessed using two sam-
ple unequal variance t tests as preliminary analysis was
performed in the absence of an appropriate rationale as
to the direction of the relationship. In the results and
discussion, we refer to P-values <0.05 as significant. The
coefficient of variation was calculated for correlation
plots to assess the fit of simple linear regressions.
Results and discussion
Total RNA yield
All 4 methods successfully extracted RNA (determined
as generating a measurable signal using the Qubit) from
as little as one 5 μm section, with geometric mean RNA
yields greater than 100 ng (Table 1/Fig. 1). The Qiagen
RNeasy FFPE extraction kit gave a superior geometric
mean RNA yield of 398 ng; however, the difference in
the performance of the RNeasy single RNA extraction
and the AllPrep DNA/RNA FFPE kit was not significant
(P-value 0.16).
Both Qiagen RNA extraction kits significantly outper-
formed the Artcturus paradise plus FFPE RNA isolation
kit and the automated Maxwell 16 LEV RNA FFPE Kit.
The RNeasy FFPE Kit gave geometric mean RNA yields
166 ng greater than the Maxwell 16 and 200 ng greater
than the Artcturus paradise plus FFPE RNA isolation
kit. The AllPrep gave geometric mean RNA yields 36 ng
greater than the Maxwell 16 and 70 ng greater than the
Arcturus paradise plus FFPE RNA isolation kit. Multiple
factors may contribute to the lower RNA yields obtained
using the Artcturus paradise plus FFPE RNA isolation
kit. Firstly, the lower temperature used during tissue
digestion may less efficiently reverse formaldehyde-
induced cross links between nucleic acids and proteins,
previous studies have reported heating tissues at higher
temperatures (>50 °C) as being more efficient [13, 23].
Also the lengthy 5 h digestion time may not be neces-
sary as previous papers have published that no more
than 3 h is required [24]. Finally, this method uses less
than half the elution volume of the two Qiagen kits poten-
tially compromising the efficiency of the elution buffer to
cover the silica membrane which could contribute to the
lower RNA yield observed. Despite the lower yield, the
Artcturus kit gave the highest RNA concentration which
may be desirable for some studies (Table 1).
Fig. 1 Comparison of Qubit RNA yields obtained using four off the shelf extraction kits: Geometric mean RNA yield and associated geometric
standard error of mean for the four extraction kits tested in this study, n = 30 for each method. P-values show the statistical significance of the
difference in yield between each method
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The Maxwell 16 RNA extraction is the only method
that does not involve deparaffinisation; we hypothesise
that excess paraffin may reduce the efficiency of cell
lysis, since some studies have shown deparaffinisation
to be a key pre-treatment step [25]. In addition, this
protocol uses paramagnetic beads for purification as
opposed to silica columns. The speed at which the
beads are mixed with the cell lysate has been shown to
have a strong influence on the efficiency of nucleic acid
binding with faster mixing speeds being linked to
higher RNA yields. Furthermore, the process of trans-
ferring the beads through a series of wash buffers can
result in the loss of beads which will negatively impact
yield. Although the Maxwell 16 automated the binding,
washing, and elution steps, up-front sample preparation
was required which took approximately 2 h before
loading the lysate onto the machine. In addition, it lim-
ited the number of samples processed per run to 16 as
opposed to batches of 24, which we feel can comfort-
ably be processed using any of the manual extraction
kits. This shows the automated RNA extraction on the
Maxwell 16 provides no increase in throughput, and we
saw no advantage in terms of yield when using this
bead based purification method for RNA extraction
over silica columns.
Based on this data, the Qiagen kits (AllPrep and RNeasy)
demonstrated superior performance when mRNA expres-
sion and quantity of RNA is the priority. However, if
quality is key and quantity of less importance, we would
recommend the automated Maxwell 16 LEV FFPE kit
(Fig. 2).
Fluorescence vs. absorbance for RNA quantification
Each of the extracted RNA samples were quantified
using both the Qubit RNA HS fluorescence based assay
and the Nanodrop 2000 spectrophotometer (for 5 sam-
ples there was insufficient sample remaining to run on
the Nanodrop). The Nanodrop also generated A260/
A280 ratios as a means of assessing purity. All four RNA
extraction kits gave mean ratios ≥1.8 indicating good
purity.
Nanodrop consistently underestimated the RNA con-
centration due to the lower sensitivity of the assay
(Additional file 2: Figure S2). The limit of detection of
the Nanodrop 2000 is 2 ng/μl whereas for the Qubit it
is 0.25 ng/μl; 37% of the samples extracted using the
Maxwell 16 gave RNA concentrations <2 ng/μl but
greater that 0.25 ng/μl and therefore fell within the back-
ground noise of the Nanodrop assay but not the Qubit.
For these reasons we chose to use RNA concentration
Fig. 2 Flow diagram summarising the key points from this study: Decision tree to highlight which extraction kits demonstrated superior performance
in terms of nucleic acid yield and quality as well as guidance on how to quantify and QC the extracted material
Seiler et al. BMC Clinical Pathology  (2016) 16:17 Page 6 of 13
readings generated from the Qubit in all subsequent
analyses.
Effect of tissue input on RNA concentration/yield using a
fixed elution volume
Total nucleic acid yield and concentration are influenced
by the elution volume and the amount of tissue proc-
essed. We investigated the effect of varying the amount
of tissue on nucleic acid concentration and yield by pro-
cessing 5 μm, 10 μm, 15 μm, 20 μm and 25 μm of tissue.
The Qiagen extraction kits demonstrated a clear linear
relationship in concentration with increasing tissue
amount (Fig. 3). The Dual extraction kit showed extrac-
tion efficiencies of up to 87% (assuming the 5 μm section
has 100% extraction efficiency) when processing ≤15 μm
of tissue. The RNeasy FFPE kit gave extraction efficiencies
of 86% when processing up to 20 μm of tissue, above this
the efficiencies were much less. We felt these small losses
in yield ( ̴14%) were an acceptable compromise for the
increase in concentration achieved through combining
tissue sections (Fig. 3a and b). However, the Arcturus
Paradise plus RNA extraction kit showed extraction effi-
ciencies between 55 and 60% when processing between 10
and 25 μm of tissue; 45% of the RNA was lost through
combining the tissue sections (Fig. 3c). The Maxwell 16
automated RNA extraction method had a very narrow
linear range of 5–10 μm tissue. Within this range, 80% ex-
traction efficiency was obtained, but when >10 μm tissue
was used a 50% reduction in yield was observed (Fig. 3d).
Therefore, our data shows that combining tissue sections
offers no advantage in terms of yield when compared to
extracting sections individually, but does provide a method
of increasing RNA concentration although in a non-linear
fashion.
Effect of elution volume on RNA concentration/yield
using a fixed amount of tissue
In previous experiments the RNeasy FFPE kit gave super-
ior RNA yields, therefore we investigated the relationship
between RNA yield/concentration and elution volume.
a b
c d
Fig. 3 Investigating the relationship between RNA concentration and the input amount of tissue: Geometric mean increase in RNA concentration
(n = 6) when combining 5 μm sections in a linear fashion and associated standard error of mean, line of Y = X/5 represents a linear relationship a Qiagen
AllPrep DNA/RNA FFPE kit, b Qiagen RNeasy, c Arcturus Paradise plus FFPE RNA isolation kit, d Maxwell 16 LEV RNA FFPE Purification kit
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12 μl, 20 μl, 30 μl 40 μl and 50 μl elution volumes were
tested using 5 μm of tissue from four different FFPE can-
cer cell line blocks.
Results showed a 20 μl elution volume was optimal
and resulted in high RNA yields and RNA concentra-
tions (Additional file 3: Figure S3). However, we acknow-
ledge that the amount of RNA bound to the column will
also have an impact on elution efficiency; samples with
higher amounts of RNA may require larger elution
volumes.
RNA quality assessment: Agilent vs RT-PCR
RNA samples with a concentration ≥5 ng/μl (limit of de-
tection of the Agilent nano assay), obtained using four
different extraction kits, were analysed for quality using
the Agilent RNA 6000 nano assay. The assigned RNA
integrity number (RIN) values were compared to the in
house multiplex RT-PCR assay as an assessment of
amplifiable RNA. The RNA samples fell into two groups,
those obtained from FFPE cell line pellets generated
<6 months prior to commencing the study and those
obtained from FFPE cell line pellets generated >2 years
prior to commencing the study.
The percentage of samples assigned a RIN value varies
between the kits tested: 69% of samples were assigned a
RIN value for the Arcturus Paradise Plus RNA kit, 13%
for the Maxwell 16 LEV RNA FFPE kit, 64% for the
AllPrep DNA/RNA FFPE kit and 71% for the Qiagen
RNeasy FFPE kit. However, the assigned RIN values
failed to show any significant differences in the quality
of the RNA released (Fig. 4a).
To allow for a more sensitive, quantitative assessment of
RNA quality isolated from FFPE samples, we developed a
multiplex PCR assay in house targeting 3 housekeeping
genes ActB, RPL19 and RPLP0 to asses RNA quality based
on the ability to amplify targets. The multiplex PCR assay
showed good concordance with single-plex PCR assays for
each housekeeping gene (Additional file 4: Figure S4) and
little intra-assay variation was seen, demonstrated by the
strong correlation (R2 value of 0.985) between technical
replicates (Additional file 5: Figure S5). Only RNA sam-
ples that were at a concentration ≥5 ng/μl were analysed
in this assay.
The multiplex PCR assay was able to demonstrate sta-
tistically significant differences in the quality of the RNA
released from the different age FFPE blocks (Fig. 4b).
Across all the extraction kits, lower quality RNA was ob-
tained from the blocks fixed between 2 and 3 years ago
than those fixed <6 months ago. Furthermore, differ-
ences in the quality of the RNA released from different
RNA extraction kits were also found to be statistically
significant. The Maxwell 16 gave significantly higher
quality RNA (lowest mean Cq value) than the three
other extraction methods, although only 50% of samples
were >5 ng/μl indicating a compromise in yield. The
mean Cq value for the Maxwell 16 was 25.9, 2.4 Cq
lower than the Arcturus Paradise Plus FFPE RNA isola-
tion kit, 1.6 Cq lower than the RNeasy and 2.0 Cq lower
than the Dual extraction kit. The Maxwell 16 is the only
method which uses paramagnetic beads and the lack of
mechanical force applied through centrifugation in this
extraction technique may account for the higher quality
of the RNA released. No significant differences in the
mean Cq values between the two Qiagen extraction kits
were seen. This data demonstrates the in house multiplex
PCR assay is a much more sensitive approach, allowing
multiple measures of RNA quality from minimal amounts
of sample.
Total amplifiable DNA recovery
A total of 120 DNA samples from 6 different FFPE cell
line pellets were obtained using four different DNA
extraction kits. 5–25 μm of tissue from each block was
processed using each method. DNA concentration was
quantified based on the amplification of a 41 bp DNA
target from a conserved single copy DNA locus. Due to
Qiagen kits not retaining products <100 bp, the DNA
concentration was also quantified using amplication of a
129 bp DNA target.
All four kits successfully extracted amplifiable DNA
from all samples as judged by a Cq value <35 for ampli-
fication of the 41 bp and 129 bp targets. PicoPure gener-
ated a superior geometric mean DNA yield of 172 ng in
41 bp assay in comparison to the Maxwell 16 (88 ng),
QIAmp (40.9 ng) and AllPrep (10.1 ng) (Fig. 5/Table 1).
However, the difference in yield seen between the Max-
well 16 and PicoPure were not significant (P-value 0.17).
Single and dual DNA extraction kits from Qiagen gave
significantly lower DNA yields than the other two kits,
but were not significantly different from each other. The
same conclusions were drawn from the 129 bp assay
(Fig. 5). The PicoPure kit from Life Technologies is a
single tube extraction method, thus avoiding the need to
bind DNA to a solid interphase followed by laborious
wash steps prior to eluting, all potentially resulting in
lower DNA yields. This method comprises solely of a
24 h Proteinase K digestion which may account for the
higher yields as longer incubation periods have been
linked to the increased release of amplifiable DNA
through more efficient reversal of formaldehyde induced
cross linking [24]. Also, in contrast to the other kits
tested, Proteinase K is stored in a lyophilised form in the
PicoPure kit and is only reconstituted prior to extraction
thus maintaining optimal enzyme activity. Furthermore,
the PicoPure kit elutes DNA in a total volume of 150 μl,
three times that of the other methods, which may also
contribute to the superior yields (Table 1). Although
the Maxwell 16 uses a magnetic particle movement
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automated extraction process, the total hands on time
was greater than the manual PicoPure kit and there-
fore provided no advantage in terms of yield or
efficiency.
Based on this data, the Arcturus PicoPure DNA extrac-
tion kit demonstrated superior performance in terms of
DNA yield from FFPE tissue.
Effect of tissue input on DNA concentration/yield using a
fixed elution volume
Each DNA extraction method was tested using 5 μm,
10 μm, 15 μm, 20 μm and 25 μm of tissue from 6 different
FFPE cancer cell line pellets. The relationship between
DNA concentration, quantified by qPCR as above, and
amount of tissue processed was investigated.
a
b
Fig. 4 Comparison of the Agilent RNA assay and our in house PCR assay for assessing RNA quality: a Agilent RNA assay, graph shows Geometric
mean RIN values and associated standard error of mean for RNA samples extracted using four different RNA extraction kits from FFPE blocks
<6 months of age or between 2 and 3 years of age. N represents the percentage of samples analysed that were assigned a RIN value. b In-house
PCR assay, graph shows Mean Cq value for the amplification of three housekeeping genes: ACTB, RPLP0 and RPL19 for sample duplicates, for RNA
samples extracted using four different RNA extraction kits from FFPE blocks either <6 months of age (blue) or between 2 and 3 years of age (pink),
horizontal black lines represent the mean Cq for the entire sample population, with pink and blue lines for the two subgroups of FFPE blocks, N
represents the percentage of samples analysed assigned a Cq value
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Fig. 5 Comparison of DNA yields obtained using four off the shelf extraction kits assessed by amplification of a conversed 41 bp or 129 bp
target: GeoMean DNA yield and associated standard error of geomean for the four extraction kits tested in this study, n = 30 for each method
c 
Arcturus PicoPure DNA extraction kit 
d 
Maxwell 16 FFPE Tissue LEV DNA Purification kit 
a
Qiagen AllPrep DNA/RNA FFPE 
b
Qiagen QIAmp DNA FFPE tissue 
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Fig. 6 Investigating the relationship between DNA concentration and the input tissue amount: Geometric mean increase in DNA concentration across
6 different FFPE blocks when combining 5 μm sections in a linear fashion and associated standard error of geomean, line of Y = X/5 represents a linear
relationship a Qiagen AllPrep DNA/RNA FFPE, b Qiagen QIAmp DNA FFPE tissue, c Arcturus PicoPure DNA extraction kit, d Maxwell 16 FFPE Tissue LEV
DNA Purification Kit
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Differences in extraction efficiencies were observed
across the 4 kits tested. The Dual kit showed extraction
efficiencies between 79 and 90% when processing up to
20 μm of tissue. The efficiency decreased by 55% when
extracting >20 μm suggesting processing >20 μm of tis-
sue in a single extraction would not be recommended
due to potential loss of DNA (Fig. 6a). The QIAmp
DNA FFPE extraction kit demonstrated a linear relation-
ship between DNA concentration and the input amount
of tissue (Fig. 6b). The Arcturus PicoPure DNA kit and
the Maxwell 16 FFPE Tissue LEV DNA purification kit
both produced extraction efficiencies >100% when pro-
cessing up to 20 μm of tissue (Fig. 6c, d) indicating that
for these kits using 5 μm sections is not optimal.
Overall results showed that extraction from 20 μm tis-
sue sections gave optimal yields across all the kits (Fig. 2).
DNA quality assessment
The quality of 120 DNA samples extracted from differ-
ent age FFPE blocks using four different extraction kits
was assessed using two qPCR assays targeting a 41 bp
amplicon and a 129b amplicon from a conserved single
copy DNA locus. The ratio between the concentration
of the 129 bp amplicon and 41 bp amplicon (Q ratio)
was used as a measure of DNA quality as fragmentation
will impact the amplification of the longer DNA target,
resulting in a lower ratio. However, running this assay in
the recommended 20 μl reaction volume with sample
duplicates, limits the ability to assess the quality of
scarce clinical samples, so the assay was miniaturised to
a 3.0 μl reaction volume.
All DNA extraction kits released higher quality DNA
from FFPE blocks <6 months old with higher Q ratios
(Fig. 7). The qPCR assay did show differences in the
quality of the DNA released using different extraction
kits. Significantly lower mean Q ratio of 0.37 was obtained
with the Arcturus PicoPure DNA extraction kit compared
to the other 3 DNA extraction methods, which were not
significantly different to each other. The difference in
mean ratio between the single and dual DNA extraction
kits from Qiagen was a mere 0.1, showing that neither
yield nor quality is compromised through dual extraction
procedures.
Silica column and bead based extractions rely on the
DNA binding ability of a solid phase. The columns sup-
plied in the Qiagen single and dual DNA extraction kits
are only able to bind DNA molecules ≥100 base pairs in
length, resulting in the loss of the 41 bp fragment and
Fig. 7 Comparison of the quality of DNA released using four off the shelf extraction kits: Relative quality of DNA samples calculated by
normalising the concentration of 129 bp amplicon to the 41 bp amplicon using the KAPA Biosystems kit. from 6 different FFPE blocks either
<6 months of age (blue) or between 2 and 3 years of age (pink), horizontal black lines represent the mean Cq for the entire sample population,
with pink and blue lines for the two equal subgroups of FFPE blocks
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selective enrichment of DNA fragments ≥100 base pairs.
This leads to an over estimation of the ratio between the
129 bp target and the 41 bp target, so caution when ana-
lysing this data is required. In contrast, the Picopure
DNA extraction kit is not reliant on the binding of DNA
molecules to a solid phase and therefore all DNA frag-
ments are retained, giving a more realistic representation
of the quality of the DNA released from FFPE samples.
Data showed the miniaturised KAPA assay can be used
to assess quantity and quality of DNA extracted without
sacrificing large amounts of DNA (Fig. 7).
Conclusions
Previous publications have compared the performance
of manual FFPE extraction kits [16–18] and automated
and manual kit counterparts [19–22], but different sam-
ples and methods for quantifying and assessing quality
makes comparisons challenging. We have presented a
comprehensive analysis of seven selected kits with a sin-
gle sample set and compared directly platforms to assess
quantity and quality of nucleic acids.
This study demonstrates that a number of factors influ-
ence the quantity and quality of nucleic acids obtained
from FFPE samples, including the age of the samples, the
extraction method, the amount of tissue processed and
the elution volume. Following the manufacturer’s instruc-
tions, the data showed that no single protocol will consist-
ently release high yields of high quality nucleic acids
across all sample types.
Perhaps not surprisingly, our data shows that super-
ior performance in high yields will often result in a
compromise in concentration and/or quality. Therefore,
downstream applications and nature of the samples to
be tested should be given consideration up front before
choosing the extraction method to apply.
Although FFPE cell line material was used in this
study to remove sample heterogeneity, and supply issues,
Qiagen RNeasy FFPE kit has been successfully utilised
on clinical FFPE samples following this study [26]. Indi-
cating that conclusions from this study are applicable to
clinical FFPE tissue samples.
To potentially improve the performance of the kits
tested in this study a wider validation study would need
to be conducted, to test variables such as; method of
deparaffinisation (deparaffinisation buffers vs. xylene),
lysis volume and incubation time, column vs. cell lysate
DNase digestion (for RNA isolation), and testing reagents
such as Proteinase K from a lyophilised stock rather than
a readymade solution.
This study successfully highlighted the key benefits of
each extraction method tested, following the manufac-
turer’s protocols, with the aim to aid scientists in choosing
a particular method dependent on individual goals. We
provide a flow diagram to help question the properties
that are most important to the success of studies with
additional information around the most accurate and effi-
cient methods to quantify and QC the extracted material
(Fig. 2).
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